News Industry News FDA Approves Impella 5.0 and Impella LD Extended Duration of Use to 14 Days for Cardiogenic Shock Derived from AMI or Cardiomyopathy May 13, 2019
News Industry News Cordis and Medinol Announce FDA Approval of the Innovative EluNIR Drug-Eluting Stent System November 30, 2017
News Industry News TherOx Enrolls First Patient in Study of Next-Generation Supersaturated Oxygen Therapy for AMI February 17, 2016
News Industry News First U.S. Patients Enroll in Boehringer Ingelheim's Global RE-DUAL PCI™ and RE-CIRCUIT™ Trials Evaluating Pradaxa® (dabigatran etexilate mesylate) July 29, 2015